HIV Treatment Strategies
The Latest

This Week in HIV Research: Resistance (Testing) Is Futile
Dec. 5, 2019: The value of pre-treatment drug resistance testing; resistance rates among viremic Americans; persistent pneumonia incidence among people with HIV; mixed HIV prevention results for the U.S. National HIV Strategy.

Coordinating Re-Entry Care Is Essential for Incarcerated People With HIV
Re-entry planning can help prevent opioid overdose and enable people living with HIV to connect with and stay in care.

Top 10 HIV Clinical Developments of 2019
Will a given development in HIV make a difference in the clinic? Will it change practice? Is this something I should know if I take care of people living with HIV? The answer to each of these must be yes for the story to make the list.

TANGO, the Most Relevant Two-Drug Antiretroviral Therapy Trial of the Year
Whether lamivudine/dolutegravir is sufficient to achieve and maintain viral suppression was last year's question. As we move to 2020, a new question could be asked: Are three-drug regimens still necessary?

ATLAS, FLAIR, and the Upcoming Arrival of Long-Acting Injectable HIV Treatment
The likely launch of injectable cabotegravir/rilpivirine in early 2020 will be interesting, writes David Wohl, M.D. One big question: How smoothly will the rollout go?

DAWNING Study Casts New Light on the Details of Resistance
The findings will help providers manage patients who have known or potential resistance to NRTIs, but who we want to place on a simplified antiretroviral regimen.

Nurses' Beliefs and Attitudes Toward Transgender Patients Affect Care
Transgender people face discrimination in many facets of life. When it comes to discrimination in clinical settings, it can affect their health for the worse.

This Week in HIV Research: How Many Pills Can a Person Miss?
Nov. 20, 2019: Adherence required to maintain suppression; the accuracy of Framingham scores in assessing cardiovascular risk; long-term success rates for kidney transplants; integration of hypertension services with HIV care.

Black Women Living With HIV Deserve Care Tailored to Them
A systematic review of research between 2000 and 2016 found no studies of interventions specifically designed to support medication adherence among HIV-positive black women.

Patients With HIV Should Think About How Many Pills They Take a Day
Taking more than five medications could be a problem. And many people with HIV are at risk of being on medication overload.